Home LiteratureArticle Details
PMID: 6457546 Published · ppublish fre Comparative Study English Abstract Journal Article

[Structure-activity relationships in the quinolone group: antibacterial activity of two new compounds (author's transl)].

Relations structure-activité dans le groupe des quinolones: étude de l'activité antibactérienne de deux nouveaux composés.

Annales de microbiologie ·Vol. 132 ·No. 3 ·1981-00-00 ·Pages 267-81

Thibault M, Koumaré B, Soussy CJ, Duval J

Abstract

Authors describe structure-activity relationships in quinolone group and report a study of the antibacterial activity of two new compounds: pefloxacin and its demethyl derivative, AM-715. These two products take place in the field of researches carried out for extending indications of this group of antimicrobial agents by obtaining derivatives more active, with broader spectrum, less biotransformed and susceptible to be used in general infections and not only in urinary tract infections.

MeSH Terms
Anaerobiosis Bacteria/drug effects Bacteriuria/drug therapy Enterobacteriaceae/drug effects Gram-Negative Aerobic Bacteria/drug effects Humans Nalidixic Acid/analogs & derivatives,pharmacology Norfloxacin Oxolinic Acid/pharmacology Pefloxacin Pipemidic Acid/pharmacology Quinolines/pharmacology Structure-Activity Relationship
Chemicals
Quinolines Pefloxacin Nalidixic Acid Oxolinic Acid Pipemidic Acid Norfloxacin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Thibault M
Koumaré B
Soussy C J
Duval J
Article Info
Journal
Annales de microbiologie
Abbr.
Ann Microbiol (Paris)
ISSN
0300-5410
Published
1981-00-00
Pages
267-81
Language
fre
Region
France
NLM ID
0354704
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]